Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Wissenschaftlicher Artikel
Authors
van Steenoven, Inger
Koel-Simmelink, Marleen J. A.
Vergouw, Leonie J. M.
Tijms, Betty M.
Piersma, Sander R.
Institutions
UKU. Klinik für NeurologiePublished in
Molecular neurodegeneration ; 15 (2020), 1. - Art.-Nr. 36. - eISSN 1750-1326
Link to publication
https://dx.doi.org/10.1186/s13024-020-00388-2Keywords
Biomarkers; Cerebrospinal fluid; Dementia with Lewy bodies; Lewy body dementia; Proteomics; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; VGF PEPTIDES; GENE-PRODUCT; ALZHEIMERS; DIAGNOSIS; QUANTIFICATION; NARP; MANAGEMENT; DYNORPHINDewey Decimal Group
DDC 570 / Life sciencesDDC 610 / Medicine & health